Binary and Ternary Inclusion Complexes of Niflumic Acid: Synthesis, Characterization, and Dissolution Profile.
2-hydroxypropyl-β-cyclodextrin
complexation efficiency
dissolution profile
drug delivery
inclusion complex
niflumic acid
solubility
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
09 Sep 2024
09 Sep 2024
Historique:
received:
15
08
2024
revised:
01
09
2024
accepted:
04
09
2024
medline:
28
9
2024
pubmed:
28
9
2024
entrez:
28
9
2024
Statut:
epublish
Résumé
Although niflumic acid (NA) is one of the most used non-steroidal anti-inflammatory drugs, it suffers from poor solubility, low bioavailability, and significant adverse effects. To address these limitations, the complexation of NA with cyclodextrins (CDs) is a promising strategy. However, complexing CDs with low molecular weight drugs like NA can lead to low CE. This study explores the development of inclusion complexes of NA with 2-hydroxypropyl-β-cyclodextrin (2HP-β-CD), including the effect of converting NA to its sodium salt (NAs) and adding hydroxypropyl methylcellulose (HPMC) on complex formation. Inclusion complexes were prepared using co-evaporation solvent and freeze-drying methods, and their CE and Ks were determined through a phase solubility study. The complexes were characterized using physicochemical analyses, including FT-IR, DSC, SEM, XRD, DLS, UV-Vis,
Identifiants
pubmed: 39339226
pii: pharmaceutics16091190
doi: 10.3390/pharmaceutics16091190
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : UEFISCDI
ID : PN-III-P4-ID-PCE-2020-2687
Organisme : UEFISCDI
ID : PNIII-P4-ID-PCE-1523